Biography
Andrea is a research assistant working within the Centre of Affective Disorders at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. She has a bachelor’s degree in Medicine and master’s degree in Psychology of Mental Health from University of Copenhagen and London Metropolitan University, respectively.
Since 2019 she has worked at KCL on several clinical studies, including R-Link, ELICE-BD and PAX-BD, where her main role is doing clinical assessments with study participants. Other work includes systematic reviews and study recruitment.
Andrea has worked both in clinical practice and research in the field of psychiatry and her main areas of expertise are bipolar disorder, obsessive compulsive disorder, and lithium treatment.
Research interests
- Bipolar disorder
- The bipolar spectrum
- Affective disorders
- Obsessive compulsive disorder
- Cognitive impairment in people with mental illness
- Lithium treatment
- Psychoeducation
- Clinical trials
- Literature review and meta-analysis
Research
Centre for Affective Disorders (CfAD)
The Centre for Affective Disorders (CfAD) focuses on mood and anxiety disorders, common disorders which cause great suffering for many people.
Optimising response to lithium treatment through personalized evaluation of individuals with bipolar I disorder: The R-Link initiative
The R-Link study aims to find out which factors predict future response to lithium treatment in the long-term.
Project status: Ongoing
A 6-week Randomised, Double-Blind, Placebo-Controlled, Multicentre Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)
Comparing the difference in cognitive functioning in people treated with Lurasidone vs. placebo, to observe if the active treatment has any influence.
Project status: Ongoing
Research
Centre for Affective Disorders (CfAD)
The Centre for Affective Disorders (CfAD) focuses on mood and anxiety disorders, common disorders which cause great suffering for many people.
Optimising response to lithium treatment through personalized evaluation of individuals with bipolar I disorder: The R-Link initiative
The R-Link study aims to find out which factors predict future response to lithium treatment in the long-term.
Project status: Ongoing
A 6-week Randomised, Double-Blind, Placebo-Controlled, Multicentre Study to Evaluate the Efficacy of Lurasidone Adjunctive Therapy in Improving Cognitive Functioning in Euthymic Bipolar Disorder Patients (ELICE-BD)
Comparing the difference in cognitive functioning in people treated with Lurasidone vs. placebo, to observe if the active treatment has any influence.
Project status: Ongoing